150 related articles for article (PubMed ID: 15262130)
21. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.
Kato Y; Iwama A; Tadokoro Y; Shimoda K; Minoguchi M; Akira S; Tanaka M; Miyajima A; Kitamura T; Nakauchi H
J Exp Med; 2005 Jul; 202(1):169-79. PubMed ID: 15998795
[TBL] [Abstract][Full Text] [Related]
22. Nuclear translocation of phosphorylated STAT3 regulates VEGF-A-induced lymphatic endothelial cell migration and tube formation.
Okazaki H; Tokumaru S; Hanakawa Y; Shiraishi K; Shirakata Y; Dai X; Yang L; Tohyama M; Hashimoto K; Sayama K
Biochem Biophys Res Commun; 2011 Sep; 412(3):441-5. PubMed ID: 21835168
[TBL] [Abstract][Full Text] [Related]
23. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3.
Meyer T; Gavenis K; Vinkemeier U
Exp Cell Res; 2002 Jan; 272(1):45-55. PubMed ID: 11740864
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
Huang M; Page C; Reynolds RK; Lin J
Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylated KDR can be located in the nucleus of neoplastic cells.
Blazquez C; Cook N; Micklem K; Harris AL; Gatter KC; Pezzella F
Cell Res; 2006 Jan; 16(1):93-8. PubMed ID: 16467880
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of signal transducers and activators of transcription during human adipogenesis.
Harp JB; Franklin D; Vanderpuije AA; Gimble JM
Biochem Biophys Res Commun; 2001 Mar; 281(4):907-12. PubMed ID: 11237746
[TBL] [Abstract][Full Text] [Related]
28. Differential activation of the STAT pathway by angiotensin II via angiotensin type 1 and type 2 receptors in cultured human fetal mesangial cells.
Seebach FA; Welte T; Fu XY; Block LH; Kashgarian M
Exp Mol Pathol; 2001 Jun; 70(3):265-73. PubMed ID: 11418005
[TBL] [Abstract][Full Text] [Related]
29. VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.
Santos SC; Miguel C; Domingues I; Calado A; Zhu Z; Wu Y; Dias S
Exp Cell Res; 2007 May; 313(8):1561-74. PubMed ID: 17382929
[TBL] [Abstract][Full Text] [Related]
30. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.
Paukku K; Silvennoinen O
Cytokine Growth Factor Rev; 2004 Dec; 15(6):435-55. PubMed ID: 15561601
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
32. [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
Wang XH; Li SS; Yan AH; Lu CX; Guo YP
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):441-4. PubMed ID: 16624747
[TBL] [Abstract][Full Text] [Related]
33. Activation of formyl peptide receptor-like 1 by WKYMVm induces serine phosphorylation of STAT3, which inhibits its tyrosine phosphorylation and nuclear translocation induced by hydrogen peroxide.
Jo EJ; Lee HY; Kim JI; Kang HK; Lee YN; Kwak JY; Bae YS
Life Sci; 2004 Sep; 75(18):2217-32. PubMed ID: 15325847
[TBL] [Abstract][Full Text] [Related]
34. Glucose is a key regulator of VEGFR2/KDR in human epithelial ovarian carcinoma cells.
Adham SA; Coomber BL
Biochem Biophys Res Commun; 2009 Dec; 390(1):130-5. PubMed ID: 19782046
[TBL] [Abstract][Full Text] [Related]
35. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
36. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
37. Interferon induces the interaction of prothymosin-alpha with STAT3 and results in the nuclear translocation of the complex.
Yang CH; Murti A; Baker SJ; Frangou-Lazaridis M; Vartapetian AB; Murti KG; Pfeffer LM
Exp Cell Res; 2004 Aug; 298(1):197-206. PubMed ID: 15242774
[TBL] [Abstract][Full Text] [Related]
38. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
[TBL] [Abstract][Full Text] [Related]
40. [Effect of monoclonal antibody against extracellular domain III of vascular endothelial growth factor receptor KDR on proliferation of vascular endothelial cells].
Li R; Xiong DS; Shao XF; Xu YF; Zhu ZP; Yang CZ
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):209-12. PubMed ID: 15949417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
